Android app on Google Play

Icahn Wants to Speak with Enzon Pharma (ENZN) Execs Over Operations, Co. Direction

November 28, 2012 9:50 AM EST Send to a Friend
Activist investor Carl C. Icahn filed an amended 13D with respect to his stake in Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN).

The amended 13D states:

"The Reporting Persons have informed the Issuer that they wish to discuss the operations and direction of the Issuer and the Issuer’s plans to manage expenses and preserve value for shareholders. Following those discussions, the Reporting Persons expect to form a view on the appropriate course of action in respect of the Issuer."




You May Also Be Interested In


Related Categories

13Ds, Hedge Funds

Related Entities

Carl Icahn, 13D

Add Your Comment